Literature DB >> 26088710

Osteocalcin and type 2 diabetes risk in Latinos: a life course approach.

Zoe M González-García1, Iftikhar J Kullo2, Dawn K Coletta3,4, Lawrence J Mandarino3,4, Gabriel Q Shaibi1,3,5.   

Abstract

OBJECTIVE: To examine associations between circulating levels of the bone-derived protein osteocalcin (OC) and type 2 diabetes (T2D) risk in Latino children and adults.
METHODS: Serum OC was measured in 136 children and 531 adults who had the following T2D risk factors assessed, body mass index (BMI), Hemoglobin A1c (HbA1c), fasting and 2-hour glucose during an oral glucose tolerance test.
RESULTS: OC was significantly higher in children than adults (209.0 ± 12.1 vs. 41.0 ± 0.9 ng/ml, p<0.0001). In adults, OC was inversely associated (all p<0.001) with BMI (r=-0.2), HbA1c (r=-0.2), fasting glucose (r=-0.16), and 2-hour glucose (r=-0.21), while there were no significant associations in children. There was a stepwise decrease in OC with increasing dysglycemia in adults, normoglycemic (44.1 ± 1.3 ng/ml), prediabetic (39.3 ± 1.3 ng/ml), and T2D (31.8 ± 1.2 ng/ml), (p<0.0001), whereas there were no differences between normal and prediabetic youth (195.7 ± 16.1 vs. 194.7 ± 25.8 ng/ml, p=0.3).
CONCLUSIONS: OC was inversely associated with T2D risk in Latino adults; however, this pattern was not observed in children.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Disparities; Hispanic; IGT; Pediatrics

Mesh:

Substances:

Year:  2015        PMID: 26088710      PMCID: PMC6822613          DOI: 10.1002/ajhb.22745

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  18 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

2.  Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation.

Authors:  Jianwen Wei; Mathieu Ferron; Christopher J Clarke; Yusuf A Hannun; Hongfeng Jiang; William S Blaner; Gerard Karsenty
Journal:  J Clin Invest       Date:  2014-03-18       Impact factor: 14.808

3.  Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function.

Authors:  Norman K Pollock; Paul J Bernard; Barbara A Gower; Caren M Gundberg; Karl Wenger; Sudipta Misra; Reda W Bassali; Catherine L Davis
Journal:  J Clin Endocrinol Metab       Date:  2011-04-20       Impact factor: 5.958

4.  Reduced serum concentrations of carboxylated and undercarboxylated osteocalcin are associated with risk of developing type 2 diabetes mellitus in a high cardiovascular risk population: a nested case-control study.

Authors:  Andrés Díaz-López; Mònica Bulló; Marti Juanola-Falgarona; Miguel A Martínez-González; Ramón Estruch; Maria-Isabel Covas; Fernando Arós; Jordi Salas-Salvadó
Journal:  J Clin Endocrinol Metab       Date:  2013-09-13       Impact factor: 5.958

5.  Lifetime risk for diabetes mellitus in the United States.

Authors:  K M Venkat Narayan; James P Boyle; Theodore J Thompson; Stephen W Sorensen; David F Williamson
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

6.  Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults.

Authors:  Lynda E Polgreen; David R Jacobs; Brandon M Nathan; Julia Steinberger; Antoinette Moran; Alan R Sinaiko
Journal:  Obesity (Silver Spring)       Date:  2012-04-30       Impact factor: 5.002

7.  Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0-18 years.

Authors:  M Bayer
Journal:  Osteoporos Int       Date:  2013-08-22       Impact factor: 4.507

8.  Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers.

Authors:  Kim-Anne Lê; Emily E Ventura; Jessica Q Fisher; Jaimie N Davis; Marc J Weigensberg; Mark Punyanitya; Houchun H Hu; Krishna S Nayak; Michael I Goran
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

9.  Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children.

Authors:  Anna Prats-Puig; Marta Mas-Parareda; Elena Riera-Pérez; Dolors González-Forcadell; Concepció Mier; Montserrat Mallol-Guisset; Marta Díaz; Judit Bassols; Francis de Zegher; Lourdes Ibáñez; Abel López-Bermejo
Journal:  Diabetes Care       Date:  2009-12-15       Impact factor: 19.112

10.  Endocrine actions of osteocalcin.

Authors:  Aurora Patti; Luigi Gennari; Daniela Merlotti; Francesco Dotta; Ranuccio Nuti
Journal:  Int J Endocrinol       Date:  2013-04-30       Impact factor: 3.257

View more
  3 in total

Review 1.  Association between serum osteocalcin and body mass index: a systematic review and meta-analysis.

Authors:  Hamed Kord-Varkaneh; Kurosh Djafarian; Masoud Khorshidi; Sakineh Shab-Bidar
Journal:  Endocrine       Date:  2017-08-18       Impact factor: 3.633

2.  Relationship between abnormal glucose metabolism and osteoporosis in Han Chinese men over the age of 50 years.

Authors:  Minyan Liu; Yanhui Lu; Xiaoling Cheng; Lichao Ma; Xinyu Miao; Nan Li; Boruo Sun; Shuangtong Yan; Jian Li; Chunling Li
Journal:  Clin Interv Aging       Date:  2019-02-25       Impact factor: 4.458

3.  Ageing characteristics of bone indicated by transcriptomic and exosomal proteomic analysis of cortical bone cells.

Authors:  Chenyang Zhang; Shuyu Xu; Shufan Zhang; Mengmeng Liu; Haiming Du; Ruinan Sun; Bo Jing; Yao Sun
Journal:  J Orthop Surg Res       Date:  2019-05-10       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.